Guerra Pan Advisors’s Amicus Therapeutics FOLD Stock Holding History

Guerra Pan Advisors’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,665	Closed	-$134K	–	99
2023 Q2	$134K	Hold	10,665	–	–	0.15%	98
2023 Q1	$118K	Hold	10,665	–	–	0.15%	92
2022 Q4	$130K	Sell	10,665 -3,281	-24%	-$36.9K	0.18%	90
2022 Q3	$145K	Hold	13,946	–	–	0.21%	85
2022 Q2	$139K	Hold	13,946	–	–	0.17%	96
2022 Q1	$101K	Sell	13,946 -1,195	-8%	-$11.2K	0.12%	97
2021 Q4	$175K	Buy	+15,141	New	+$169K	0.17%	109

Other funds holding FOLD

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Guerra Pan Advisors's FOLD Position: Q3 2023 in Review

Guerra Pan Advisors sold out of Amicus Therapeutics (FOLD) in Q3 2023, closing a stake of 10,665 shares — an estimated $134K sold.

Guerra Pan Advisors first reported a position in FOLD in Q4 2021 and held it in 7 quarters. The position peaked at $175K in Q4 2021. 228 funds tracked by Wall St. Rank hold FOLD as of Q3 2023.

Guerra Pan Advisors reported no remaining Amicus Therapeutics position as of Q3 2023 after selling out during the quarter.
Guerra Pan Advisors sold 10,665 Amicus Therapeutics shares in Q3 2023, an estimated $134K.
Guerra Pan Advisors first reported a position in Amicus Therapeutics in Q4 2021 and held it in 7 quarters.
Guerra Pan Advisors's Amicus Therapeutics position peaked at $175K in Q4 2021.
228 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q3 2023.

Based on Guerra Pan Advisors's 13F filing for Q3 2023, filed 9 Nov 2023.